BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 18980843)

  • 1. Identification of small molecule agonists of the motilin receptor.
    Heightman TD; Conway E; Corbett DF; Macdonald GJ; Stemp G; Westaway SM; Celestini P; Gagliardi S; Riccaboni M; Ronzoni S; Vaidya K; Butler S; McKay F; Muir A; Powney B; Winborn K; Wise A; Jarvie EM; Sanger GJ
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6423-8. PubMed ID: 18980843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of biaryl carboxamides as novel small molecule agonists of the motilin receptor.
    Westaway SM; Brown SL; Conway E; Heightman TD; Johnson CN; Lapsley K; Macdonald GJ; MacPherson DT; Mitchell DJ; Myatt JW; Seal JT; Stanway SJ; Stemp G; Thompson M; Celestini P; Colombo A; Consonni A; Gagliardi S; Riccaboni M; Ronzoni S; Briggs MA; Matthews KL; Stevens AJ; Bolton VJ; Boyfield I; Jarvie EM; Stratton SC; Sanger GJ
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6429-36. PubMed ID: 19006669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor.
    Bailey JM; Scott JS; Basilla JB; Bolton VJ; Boyfield I; Evans DG; Fleury E; Heightman TD; Jarvie EM; Lawless K; Matthews KL; McKay F; Mok H; Muir A; Orlek BS; Sanger GJ; Stemp G; Stevens AJ; Thompson M; Ward J; Vaidya K; Westaway SM
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6452-8. PubMed ID: 19804969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a potent and novel motilin agonist.
    Li JJ; Chao HG; Wang H; Tino JA; Lawrence RM; Ewing WR; Ma Z; Yan M; Slusarchyk D; Seethala R; Sun H; Li D; Burford NT; Stoffel RH; Salyan ME; Li CY; Witkus M; Zhao N; Rich A; Gordon DA
    J Med Chem; 2004 Mar; 47(7):1704-8. PubMed ID: 15027861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of non-peptidergic MrgX1 and MrgX2 receptor agonists and exploration of an initial SAR using solid-phase synthesis.
    Malik L; Kelly NM; Ma JN; Currier EA; Burstein ES; Olsson R
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1729-32. PubMed ID: 19230660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility.
    Sanger GJ; Westaway SM; Barnes AA; Macpherson DT; Muir AI; Jarvie EM; Bolton VN; Cellek S; Näslund E; Hellström PM; Borman RA; Unsworth WP; Matthews KL; Lee K
    Neurogastroenterol Motil; 2009 Jun; 21(6):657-64, e30-1. PubMed ID: 19374732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of a specific site of covalent labeling of the human motilin receptor using a biologically active photolabile motilin analog.
    Matsuura B; Dong M; Coulie B; Pinon DI; Miller LJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1101-8. PubMed ID: 15677347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists.
    Cole AG; Stroke IL; Qin LY; Hussain Z; Simhadri S; Brescia MR; Waksmunski FS; Strohl B; Tellew JE; Williams JP; Saunders J; Appell KC; Henderson I; Webb ML
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5420-3. PubMed ID: 18815029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of substituted 2,4,4-triarylimidazoline derivatives as potent and selective neuropeptide Y Y5 receptor antagonists.
    Sato N; Jitsuoka M; Ishikawa S; Nagai K; Tsuge H; Ando M; Okamoto O; Iwaasa H; Gomori A; Ishihara A; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1670-4. PubMed ID: 19233647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid assessment of a novel series of selective CB(2) agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis.
    Ryckmans T; Edwards MP; Horne VA; Correia AM; Owen DR; Thompson LR; Tran I; Tutt MF; Young T
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4406-9. PubMed ID: 19500981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motilin and motilin receptors: characterization and functional significance.
    Depoortere I
    Verh K Acad Geneeskd Belg; 2001; 63(6):511-29. PubMed ID: 11813507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of agonist-induced motilin receptor trafficking and its implications for tachyphylaxis.
    Lamian V; Rich A; Ma Z; Li J; Seethala R; Gordon D; Dubaquie Y
    Mol Pharmacol; 2006 Jan; 69(1):109-18. PubMed ID: 16221873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists.
    Johnson SG; Gunnet JW; Moore JB; Miller W; Wines P; Rivero RA; Combs D; Demarest KT
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3362-6. PubMed ID: 16650762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of N-(3-fluorophenyl)-1-[(4-([(3S)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the first small molecule motilin receptor agonist clinical candidate.
    Westaway SM; Brown SL; Fell SC; Johnson CN; MacPherson DT; Mitchell DJ; Myatt JW; Stanway SJ; Seal JT; Stemp G; Thompson M; Lawless K; McKay F; Muir AI; Barford JM; Cluff C; Mahmood SR; Matthews KL; Mohamed S; Smith B; Stevens AJ; Bolton VJ; Jarvie EM; Sanger GJ
    J Med Chem; 2009 Feb; 52(4):1180-9. PubMed ID: 19191554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacological characterization of mitemcinal (GM-611), the first acid-resistant non-peptide motilin receptor agonist, in smooth muscle of rabbit small intestine.
    Takanashi H; Yogo K; Ozaki K; Koga H; Itoh Z; Omura S
    Pharmacology; 2007; 79(3):137-48. PubMed ID: 17183187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motilin and erythromycin-A share a common binding site in the third transmembrane segment of the motilin receptor.
    Xu L; Depoortere I; Vertongen P; Waelbroeck M; Robberecht P; Peeters TL
    Biochem Pharmacol; 2005 Sep; 70(6):879-87. PubMed ID: 16076462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rabbit motilin receptor: molecular characterisation and pharmacology.
    Dass NB; Hill J; Muir A; Testa T; Wise A; Sanger GJ
    Br J Pharmacol; 2003 Nov; 140(5):948-54. PubMed ID: 14504130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable expression of a synthetic gene for the human motilin receptor: use in an aequorin-based receptor activation assay.
    Carreras CW; Siani MA; Santi DV; Dillon SB
    Anal Biochem; 2002 Jan; 300(2):146-51. PubMed ID: 11779105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification and optimisation of novel and selective diamide neuropeptide Y Y2 receptor antagonists.
    Lunniss GE; Barnes AA; Barton N; Biagetti M; Bianchi F; Blowers SM; Caberlotto L; Emmons A; Holmes IP; Montanari D; Norris R; Walters DJ; Watson SP
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4022-5. PubMed ID: 19581086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.